Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 2/20 | 0.52 |
| ▸ | HTR1D | P28221 | 1/20 | 0.51 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.49 |
| ▸ | TRPV5 | Q9NQA5 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7039447 | 0.88 | CCR1 (0.54) | HTR1D | |
| SCHEMBL7308048 | 0.87 | HTR1D (0.62) | OPRL1HTR1DTRPV6TRPV5OPRM1 | |
| SCHEMBL7040982 | 0.83 | TRPV6 (0.63) | OPRL1HTR1DTRPV6OPRM1 | |
| SCHEMBL7310103 | 0.82 | OPRL1 (0.61) | OPRL1HTR1DTRPV6TRPV5OPRM1 | |
| SCHEMBL7040198 | 0.80 | HTR1D (0.80) | HTR1D | |
| SCHEMBL7307698 | 0.77 | HTR1D (0.53) | HTR1D | |
| SCHEMBL7038207 | 0.75 | HTR1D (0.69) | OPRL1HTR1DTRPV6TRPV5 | |
| SCHEMBL7299616 | 0.74 | HTR1D (0.66) | OPRL1HTR1D | |
| SCHEMBL9036683 | 0.74 | OPRL1 (0.45) | OPRL1TRPV6TRPV5OPRM1 | |
| SCHEMBL9038176 | 0.73 | GAA (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1037637-B1 | USE OF 5HT1A RECEPTOR ANTAGONISTS FOR PREVENTING AND/OR TREATING TEMPORAL LOBE EPILEPSY | UNIV PRINCETON (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-0546583-B1 | Piperazinyl-and piperidinyl-cyclohexanols | BRISTOL MYERS SQUIBB CO (US) | 1996-05-22 | — | — | EP | disclosed |
| US-5478828-A | Anxiolytic agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-12-26 | — | — | US | disclosed |
| US-5387593-A | Anxiolytic agents | BRISTON-MYERS SQUIBB (US) | 1995-02-07 | — | — | US | disclosed |
| EP-0546583-A1 | Piperazinyl-and piperidinyl-cyclohexanols | Bristol-Myers Squibb Company (US) | 1993-06-16 | — | — | EP | disclosed |